Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The revision label has been updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a newer revision of the document in the revision history.
    Difference
    0.0%
    Check dated 2026-05-14T23:03:43.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was removed and Taoyuan, Taiwan, 333 was added in the Locations section, reflecting a corrected city designation for the recruitment site.
    Difference
    0.0%
    Check dated 2026-05-07T23:13:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.5.2 to v3.5.3. This reflects a minor update to the page's metadata or documentation.
    Difference
    0.0%
    Check dated 2026-04-30T17:23:04.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added revision note: v3.5.2; removed revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:05:03.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    - Padua, Italy, 35128 was replaced by Padova, Italy, 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-09T08:31:06.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added the disease term Hepatocellular carcinoma and a Resources section linking to the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:48:09.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.